REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 8 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -40.0% | 32,704 | -41.4% | 0.00% | – |
| Q2 2022 | $10,000 | -61.5% | 55,839 | -45.8% | 0.00% | -100.0% |
| Q1 2022 | $26,000 | -93.5% | 102,990 | -26.7% | 0.00% | -90.0% |
| Q4 2021 | $398,000 | +598.2% | 140,462 | -1.6% | 0.01% | +400.0% |
| Q3 2021 | $57,000 | -43.6% | 142,700 | -29.5% | 0.00% | -33.3% |
| Q2 2021 | $101,000 | -12.2% | 202,293 | -19.1% | 0.00% | -25.0% |
| Q1 2021 | $115,000 | -32.0% | 250,000 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $169,000 | – | 250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 200,000 | $1,749,000 | 0.06% |
| BlueCrest Capital Management Ltd | 1,220,600 | $824,000 | 0.02% |
| GLAZER CAPITAL, LLC | 690,166 | $466,000 | 0.02% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 110,900 | $75,000 | 0.01% |
| AQR Arbitrage LLC | 250,000 | $169,000 | 0.01% |
| Context Capital Management, LLC | 39,300 | $27,000 | 0.00% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 106,552 | $72,000 | 0.00% |
| Walleye Capital LLC | 64,959 | $44,000 | 0.00% |
| Polar Asset Management Partners Inc. | 300,907 | $197,000 | 0.00% |
| HRT FINANCIAL LP | 132,624 | $89,000 | 0.00% |